Literature DB >> 14557670

Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.

Patricia E Tam1, Melissa L Weber-Sanders, Ronald P Messner.   

Abstract

Mice infected with myopathic coxsackievirus B1 Tucson (CVB1(T)) develop chronic inflammatory myopathy (CIM) consisting of hind limb weakness and inflammation. Amyopathic virus variants are infectious but attenuated for CIM. In this report, viral clones, chimeras, and sequencing were used to identify viral determinants of CIM. Chimeras identified several regions involved in CIM and localized a weakness determinant to nucleotides 2493 to 3200 of VP1. Sequencing of multiple clones and viruses identified five candidate determinants that were strictly conserved in myopathic viruses with one located in the 5' untranslated region (UTR), three in the VP1 capsid, and one in the 3C protease. Taken together, these studies implicate Tyr-87 and/or Val-136 as candidate determinants of weakness. They also indicate that there are at least two determinants of inflammation and one additional determinant of weakness encoded by myopathic CVB1(T).

Entities:  

Mesh:

Year:  2003        PMID: 14557670      PMCID: PMC229355          DOI: 10.1128/jvi.77.21.11849-11854.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera.

Authors:  B Y Reimann; R Zell; R Kandolf
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.

Authors:  M Caggana; P Chan; A Ramsingh
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

3.  Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effects of host background and major histocompatibility complex genes.

Authors:  P E Tam; R P Messner
Journal:  J Lab Clin Med       Date:  1996-09

4.  Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis.

Authors:  G E Yousef; D A Isenberg; J F Mowbray
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

5.  Identification of two determinants that attenuate vaccine-related type 2 poliovirus.

Authors:  R B Ren; E G Moss; V R Racaniello
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Coxsackie B1 virus-induced murine myositis: relationship of disease severity to virus dose and antiviral antibody response.

Authors:  P J Jongen; F W Heessen; H J ter Laak; J M Galama; F J Gabreëls
Journal:  Neuromuscul Disord       Date:  1994-01       Impact factor: 4.296

7.  Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.

Authors:  P E Tam; A M Schmidt; S R Ytterberg; R P Messner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis?

Authors:  K Klingel; B M McManus; R Kandolf
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

9.  The structure of coxsackievirus B3 at 3.5 A resolution.

Authors:  J K Muckelbauer; M Kremer; I Minor; G Diana; F J Dutko; J Groarke; D C Pevear; M G Rossmann
Journal:  Structure       Date:  1995-07-15       Impact factor: 5.006

10.  Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis.

Authors:  P E Tam; A M Schmidt; S R Ytterberg; R P Messner
Journal:  J Lab Clin Med       Date:  1994-03
View more
  6 in total

1.  Adult-Onset Still's Disease: Is This Truly a Diagnosis of Exclusion?

Authors:  Caleb W Anderson; Phalgoon A Shah; Jefferson R Roberts
Journal:  Hawaii J Med Public Health       Date:  2017-11

2.  5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

Authors:  K-S Kim; S Tracy; W Tapprich; J Bailey; C-K Lee; K Kim; W H Barry; N M Chapman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  A functional nuclear localization sequence in the VP1 capsid protein of coxsackievirus B3.

Authors:  Tianying Wang; Bohai Yu; Lexun Lin; Xia Zhai; Yelu Han; Ying Qin; Zhiwei Guo; Shuo Wu; Xiaoyan Zhong; Yan Wang; Lei Tong; Fengmin Zhang; Xiaoning Si; Wenran Zhao; Zhaohua Zhong
Journal:  Virology       Date:  2012-09-23       Impact factor: 3.616

4.  Immune Transcriptome of Cells Infected with Enterovirus Strains Obtained from Cases of Autoimmune Thyroid Disease.

Authors:  Anello Marcello Poma; Sarah Salehi Hammerstad; Angelo Genoni; Alessio Basolo; Knut Dahl-Jorgensen; Antonio Toniolo
Journal:  Microorganisms       Date:  2021-04-19

5.  Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1.

Authors:  Maribeth M Sandager; Jaime L Nugent; Wade L Schulz; Ronald P Messner; Patricia E Tam
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

Review 6.  Infections and autoimmunity: a panorama.

Authors:  V Pordeus; M Szyper-Kravitz; R A Levy; N M Vaz; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.